BlackRock Fund Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISEE
SCM
TCP
BIM
BIT
BlackRock Fund Advisors's ISEE Position: Q4 2016 in Review
BlackRock Fund Advisors increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 13% in Q4 2016, buying an estimated $4.69M and bringing the position to 1,415,270 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2781.
BlackRock Fund Advisors first reported a position in ISEE in Q4 2013 and has held it in 13 quarters since. The position peaked at $77.5M in Q4 2015. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.
- BlackRock Fund Advisors held 1,415,270 shares of IVERIC bio, Inc. Common Stock worth $6.84M as of Q4 2016.
- BlackRock Fund Advisors bought 158,128 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $4.69M.
- IVERIC bio, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2781 holding.
- BlackRock Fund Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and has held it in 13 quarters since.
- BlackRock Fund Advisors's IVERIC bio, Inc. Common Stock position peaked at $77.5M in Q4 2015.
- 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.